{"DataElement":{"publicId":"6763374","version":"1","preferredName":"Laboratory Procedure HER2 Measurement IHC Test Outcome","preferredDefinition":"The result of HER2 genetic immunohistochemistry analysis.","longName":"LAB_HER2_IHC_TEST_OUTCM","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6763352","version":"1","preferredName":"Laboratory Procedure HER 2 Measurement IHC Test","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of human epidermal growth factor receptor 2 present in a sample._A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.","longName":"2543047v1.0:6763350v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6763350","version":"1","preferredName":"Human Epidermal Growth Factor Receptor 2 Measurement Immunohistochemical Test","preferredDefinition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.:A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.","longName":"C112312:C51944","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Epidermal Growth Factor Receptor 2 Measurement","conceptCode":"C112312","definition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunohistochemical Test","conceptCode":"C51944","definition":"A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8958B103-D2E3-790D-E053-F662850A45D8","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"ONEDATA","dateModified":"2019-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8958B103-D2F4-790D-E053-F662850A45D8","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeDescription":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6763373","version":"1","preferredName":"HER2 IHC Test Status Outcome","preferredDefinition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample._A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope._The result of an action.","longName":"6763373v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Data not available","valueDescription":"Source Data Not Available","ValueMeaning":{"publicId":"4842575","version":"1","preferredName":"Source Data Not Available","longName":"4842575","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-9709-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89556F21-091D-62E2-E053-F662850A53BE","beginDate":"2019-05-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"ONEDATA","dateModified":"2019-05-20","deletedIndicator":"No"},{"value":"Pending","valueDescription":"Pending","ValueMeaning":{"publicId":"2784518","version":"1","preferredName":"Pending","longName":"2784518","preferredDefinition":"Not yet decided or settled; awaiting conclusion or confirmation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pending","conceptCode":"C53470","definition":"Not yet decided or settled; awaiting conclusion or confirmation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56EFDF2C-6BD9-3BA3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2008-09-15","modifiedBy":"DWARZEL","dateModified":"2022-10-03","changeDescription":"Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89556F21-0945-62E2-E053-F662850A53BE","beginDate":"2019-04-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"ONEDATA","dateModified":"2019-05-20","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89556F21-0964-62E2-E053-F662850A53BE","beginDate":"2019-05-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"ONEDATA","dateModified":"2019-05-20","deletedIndicator":"No"},{"value":"Cannot be determined","valueDescription":"Cannot Be Determined","ValueMeaning":{"publicId":"7758876","version":"1","preferredName":"Cannot Be Determined","longName":"7758876","preferredDefinition":"An indication that a reason or result cannot be established.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cannot Be Determined","conceptCode":"C179711","definition":"An indication that a reason or result cannot be established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8BDCB33-05AB-7A20-E053-4EBD850A27B9","latestVersionIndicator":"Yes","beginDate":"2021-08-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-08-04","modifiedBy":"ONEDATA","dateModified":"2021-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2072754-E893-686F-E053-4EBD850AAD4F","beginDate":"2021-11-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-30","modifiedBy":"ONEDATA","dateModified":"2021-11-30","deletedIndicator":"No"},{"value":"Equivocal (Score 2+)","valueDescription":"HER2/Neu Expression by Immunohistochemistry 2+","ValueMeaning":{"publicId":"6117735","version":"1","preferredName":"HER2/Neu Expression by Immunohistochemistry 2+","longName":"6117735","preferredDefinition":"An immunohistochemical result of 2+ for HER2/Neu expression that is considered equivocal for expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HER2/Neu Expression by Immunohistochemistry 2+","conceptCode":"C147526","definition":"An immunohistochemical result of 2+ for HER2/Neu expression that is considered equivocal for expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66DD6F31-FA4C-12A4-E053-F662850AE423","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"COLBERTM","dateModified":"2023-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2072754-E8A8-686F-E053-4EBD850AAD4F","beginDate":"2019-05-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-30","modifiedBy":"ONEDATA","dateModified":"2021-11-30","deletedIndicator":"No"},{"value":"Not tested","valueDescription":"Not Tested","ValueMeaning":{"publicId":"3918247","version":"1","preferredName":"Not Tested","longName":"3918247","preferredDefinition":"Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8673FC8-BC14-9D61-E040-BB89AD431A7D","latestVersionIndicator":"Yes","beginDate":"2013-10-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D23F77E8-98F2-4D75-E053-4EBD850AB59E","beginDate":"2021-12-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-03","modifiedBy":"ONEDATA","dateModified":"2021-12-03","deletedIndicator":"No"},{"value":"Negative (Score 0)","valueDescription":"HER2/Neu Expression by Immunohistochemistry 0","ValueMeaning":{"publicId":"6117737","version":"1","preferredName":"HER2/Neu Expression by Immunohistochemistry 0","longName":"6117737","preferredDefinition":"An immunohistochemical result of 0 for HER2/Neu expression that is considered negative for expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HER2/Neu Expression by Immunohistochemistry 0","conceptCode":"C147524","definition":"An immunohistochemical result of 0 for HER2/Neu expression that is considered negative for expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66DD6F31-FA96-12A4-E053-F662850AE423","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D23F77E8-9906-4D75-E053-4EBD850AB59E","beginDate":"2021-12-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-03","modifiedBy":"ONEDATA","dateModified":"2021-12-03","deletedIndicator":"No"},{"value":"Negative (Score 1+)","valueDescription":"HER2/Neu Expression by Immunohistochemistry 1+","ValueMeaning":{"publicId":"6117736","version":"1","preferredName":"HER2/Neu Expression by Immunohistochemistry 1+","longName":"6117736","preferredDefinition":"An immunohistochemical result of 1+ for HER2/Neu expression that is considered negative for expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HER2/Neu Expression by Immunohistochemistry 1+","conceptCode":"C147525","definition":"An immunohistochemical result of 1+ for HER2/Neu expression that is considered negative for expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66DD6F31-FA71-12A4-E053-F662850AE423","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"COLBERTM","dateModified":"2023-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D23F77E8-991B-4D75-E053-4EBD850AB59E","beginDate":"2021-12-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-03","modifiedBy":"ONEDATA","dateModified":"2021-12-03","deletedIndicator":"No"},{"value":"Positive (Score 3+)","valueDescription":"HER2/Neu Expression by Immunohistochemistry 3+","ValueMeaning":{"publicId":"6117734","version":"1","preferredName":"HER2/Neu Expression by Immunohistochemistry 3+","longName":"6117734","preferredDefinition":"An immunohistochemical result of 3+ for HER2/Neu expression that is considered positive for expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HER2/Neu Expression by Immunohistochemistry 3+","conceptCode":"C147527","definition":"An immunohistochemical result of 3+ for HER2/Neu expression that is considered positive for expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66DD6F31-FA27-12A4-E053-F662850AE423","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2401C28-F286-35AE-E053-4EBD850A4F4C","beginDate":"2015-11-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-03","modifiedBy":"ONEDATA","dateModified":"2021-12-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6765521","version":"1","preferredName":"Human Epidermal Growth Factor Receptor 2 Measurement Immunohistochemical Test Outcome","preferredDefinition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.:A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.:The result of an action.","longName":"C112312:C51944:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Epidermal Growth Factor Receptor 2 Measurement","conceptCode":"C112312","definition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemical Test","conceptCode":"C51944","definition":"A diagnostic test in which an antibody is used to link a cellular antigen specifically to a stain that can be seen with a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"898E3C0B-8AE5-15DF-E053-F662850A8D0E","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89556F21-08F2-62E2-E053-F662850A53BE","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeDescription":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/3/21 mr Deleted Negative (0,1+) and added separate PVs for Negative(0) and Negative(1+).  Deleted Not done, added Not tested. Per MCL PCA breast DCT. 11/30/21 mr Added Cannot be determined; changed primary name from Borderline (2+) to Equivocal (2+) per MCL PCA breast DCT.   5/23/19 edits to Rep Term, Long Name; tt. 5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643184","version":"1","longName":"Surgical Therapy","context":"MCL"},{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"},{"publicId":"7035094","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001791","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"HER2_immunohistochemistry","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"HER2 by immunohistochemistry","type":"Preferred Question Text","description":"HER2 by immunohistochemistry","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"breast_v1-2_08sep2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89593FDE-92CB-5ACA-E053-F662850AE06A","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeDescription":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/3/21 mr Edited VD, def, question text for MCL PCA breast. Added alt name, ref doc, CSI per DCT.  5/23/19 edits/VD; tt. 5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}